Crystal structure of the complex of the secretory phospholipase A 2 from Daboia russelli pulchella with an endogenic indole derivative, 2-carbamoylmethyl-5-propyl-octahydro-indol-7-yl-acetic acid at 1.8 Å resolution

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1752, Issue 2, 2005, Pages 177-185

  Balasubramanya, R ^a   Chandra, Vikas ^a   Kaur, Punit ^a   Singh, Tej P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Complex; Crystal structure; Endogenic indole derivative; Phospholipase A2

Indexed keywords

2 CARBAMOYLMETHYL 5 PROPYLOCTAHYDROINDOL 7 YLACETIC ACID; ASPARTIC ACID; CALCIUM ION; ENZYME INHIBITOR; HISTIDINE; INDOLE DERIVATIVE; PHOSPHOLIPASE A2; SNAKE VENOM; UNCLASSIFIED DRUG;

ARTICLE; ATOM; BINDING SITE; CATALYSIS; CRYSTAL STRUCTURE; DABOIA RUSSELLI PULCHELLA; DENSITY; ELECTRON; ENZYME INHIBITION; ENZYME PURIFICATION; PRIORITY JOURNAL; PROTEIN INTERACTION; SNAKE; X RAY CRYSTALLOGRAPHY;

ANIMALS; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; INDOLES; LIGANDS; MODELS, MOLECULAR; PHOSPHOLIPASES A; PROTEINS; RUSSELL'S VIPER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VIPER VENOMS;

DABOIA RUSSELLII PULCHELLA;

EID: 25144520359     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2005.07.020     Document Type: Article

References (68)

1. 2 Eur. J. Biochem. 112 1980 25 32
2. 2 in human cartilage Life Sci. 48 1991 2457 2462
3. 2 Am. J. Pathol. 134 1989 807 811
4. F.M. Uckun, and C. Mao Tyrosine kinases as new molecular targets in treatment of inflammatory disorders and leukemia Curr. Pharm. Des. 10 2004 1083 1091
5. S.W. Kaldor, V.J. Kalish, J.F. Davies, B.V. Shetty, J.E. Fritz, K. Appelt, J.A. Burgess, K.M. Campanale, N.Y. Chirgadze, D.K. Clawson, B.A. Dressman, S.D. Hatch, D.A. Khalil, M.B. Kosa, P.P. Lubbehusen, M.A. Muesing, A.K. Patick, S.H. Reich, K.S. Su, and J.H. Tatlock Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease J. Med. Chem. 40 1997 3979 3985
6. S. Ren, and E.J. Lien Development of HIV protease inhibitors: a survey Prog. Drug Res. Spec. 2001 1 34
7. M. Tennant, and D.E. McRee The first structure of a microsomal P450-Implications for drug discovery Curr. Opin. Drug Discov. Dev. 4 2001 671 677
8. 2 Nat. Struct. Biol. 2 1995 458 465
9. 2-IIA complex with the potent indolizine inhibitor 120-1032 J. Biochem. 123 1998 619 623
10. 2 in a complex with a transition-state analogue Science 250 1990 1563 1566
11. 2 Eur. J. Med. Chem. 36 2001 1 19
12. 2 Eur. J. Med. Chem. 36 2001 21 30
13. A.T. Weil, and W. Davia Bufo alvarius: a potent hallucinogen of animal origin J. Ethanopharmacol. 41 1994 1 8
14. G. Cimino, and S. De Stefano Chemistry of Mediterranean Gorgonians. Simple indole derivatives from Paramuricea chamaeleon C. R. Biochem. Physiol., Ser. C 61 1978 361 362
15. L. Corbett Hallucinogenic N-methylated indole alkylamines in the cerebrospinal fluid of psychiatric and control populations Br. J. Psychiatry 132 1978 139 144
16. T. Schulze, Ein Echtheitsystem zur Messung der dynamishen Lichtstreuung in flussigkeiten, MSc thesis, University Hamburg, Hamburg, Germany, 1996.
17. Z. Otwinowski, and W. Minor Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 176 1997 307 326
18. J. Navaza AMoRe: an automated package for molecular replacement Acta Crystallogr. D57 2001 1367 1372
19. 2 from Daboia russelli pulchella at 1.9 Å resolution Acta Crystallogr. D57 2001 1793 1798
20. B.W. Matthews Solvent content of protein crystals J. Mol. Biol. 33 1968 491 497
21. G.N. Murshudov, A.A. Vagin, and E.J. Dodson Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr. D53 1997 240 255
22. T.A. Jones, J. Zou, S.W. Cowan, and M. Kjeldgaard Improved methods for building models in electron density maps and the location of errors in these models Acta Crystallogr. A47 1991 110 119
23. R.A. Engh, and R. Huber Accurate bond and angle parameters for X-ray protein structure refinement Acta Crystallogr. A47 1991 392 400
24. B.E. Dahneke Measurement of Suspended Particles by Quasi Elastic Light Scattering 1983 Wiley New York, USA
25. K.S. Schmitz An Introduction to Dynamic Light Scattering by Macromolecules 1990 Academic Press Boston, USA
26. R.B. Nair, R.K. Jaj, and P.A. Kurup Indole compounds of the venom of the South Indian scorpion, H. scaber Indian J. Biochem. Biophys. 10 1973 231 232
27. R.B. Nair, and P.A. Kurup Investigations on the venom of the South Indian scorpion Heterometrus scaber Biochim. Biophys. Acta 381 1975 165 174
28. S. Chesnov, L. Bigler, and M. Hesse The acylpolyamines from the venom of the spider, Agelenopsis apert Helv. Chim. Acta 84 2001 2178 2197
29. M.S. Palma, Y. Itagaki, T. Fujita, H. Naoki, and T. Nakajima Structural characterization of a new acylpolyaminetoxin from the venom of Brazilian garden spider Nephilengys cruentata Toxicon 36 1998 485 493
30. E.V. Grishin, T.M. Volkova, and A.S. Arseniev Isolation and structure analysis of components from venom of the spider Argiope lobata Toxicon 27 1989 541 549
31. R.A. Laskowski, M.W. MacArthur, D.S. Moss, and J.M. Thornton PROCHECK: a program to check stereochemical quality of protein structures J. Appl. Crystallogr. 26 1993 283 291
32. G.N. Ramachandran, and V. Sasisekharan Conformation of polypeptides and proteins Adv. Prot. Chem. 23 1968 283 438
33. 2 from Daboia russelli pulchella at 2.4 Å resolution J. Mol. Biol. 296 2000 1117 1126
34. J.S. Richardson, and D.C. Richardson Principles and patterns of protein conformation G.D. Fasman Prediction of Protein Structure and the Principles of Protein Conformation 1989 Plenum Press New York 1 98
35. 2 and alpha-tocopherol at 1.8 Å resolution J. Mol. Biol. 320 2002 215 222
36. 2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 Å crystal structure Biochemistry 41 2002 10914 10919
37. 2 and a potent peptide inhibitor Phe-Leu-Ser-Tyr-Lya at 1.8 Å resolution J. Biol. Chem. 277 2002 41079 41085
38. 2 and a designed peptide Leu-Ala-Ile-Tyr-Ser (LAIYS) Acta Crystallogr. D58 2002 1813 1819
39. 2 FASEB J. 8 1994 916 924
40. 2 with thioether amide containing phospholipid analogues Biochemistry 32 1999 5009 5016
41. 2 with phospholipid analogues and inhibitors J. Biol. Chem. 265 1990 2657 2664
42. T. Tani, S. Fujii, S. Inoue, K. Ikeda, S. Iwama, T. Matsuda, S. Katsumura, Y. Samejima, and K. Hayashi Binding mode of phospholipase A2 with a new type of phospholipid analog having an oxazolidinone ring J. Biochem. (Tokyo) 117 1995 176 182
43. B.S. Vishwanath, R.M. Kini, and T.V. Gowda Characterization of three edema-inducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid Toxicon 25 1987 501 515
44. 2: X-ray structure of the complex and interfacial selection of inhibitors from a structural library Bioorg. Med. Chem. Lett. 9 1999 1097 1102
45. 2 inhibitors Chem. Pharm. Bull. (Tokyo) 43 1995 1696 1700
46. 2 by novel 2-oxoamides in vitro, in cells, and in vivo J. Med. Chem. 47 2004 3615 3628
47. 2 and a naturally occurring fatty acid at 2.7 Å resolution Protein Sci. 14 2005 395 400
48. A.L.B. Ambrosio, M.C. Nonato, H.S. Selistre De Araujo, R. Arni, R.J. Ward, C.L. Ownby, D.H.F. De Souza, and R.C. Garratt A molecular mechanism for Lys49-phospholipase A2 activity based on ligand-induced conformational change J. Biol. Chem. 280 2005 7326
49. 2-a hypothesis: the crystal structure of piratoxin II complexed to fatty acid Biochemistry 40 2001 28 36
50. W.F. de Azevedo Jr., R.J. Ward, J.M. Gutierrez, and R.K. Arni Structure of a Lys49-phospholipase A2 homologue isolated from the venom of Bothrops nummifer (jumping viper) Toxicon 37 1999 371 384
51. L.A. Marshall, R.H. Hall, J.D. Winkler, A. Badger, B. Bolognese, A. Roshak, P.L. Flamberg, C.M. Sung, M. Chabot-Fletcher, and J.L. Adams SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock J. Pharmacol. Exp. Ther. 274 1995 1254 1262
52. P.A. Melo, M.C. do Nascimento, W.B. Mors, and G. Suarez-Kurtz Inhibition of the myotoxic and hemorrhagic activities of crotalid venoms by Eclipta prostrata (Asteraceae) extracts and constituents Toxicon 32 1994 595 603
53. W.B. Mors, M.C. do Nascimento, J.P. Parente, M.H. da Silva, P.A. Melo, and G. Suarez-Kurtz Neutralization of lethal and myotoxic activities of South American rattlesnake venom by extracts and constituents of the plant Eclipta prostrata (Asteraceae) Toxicon 27 1989 1003 1009
54. 2 J. Mol. Biol. 333 2003 367 376
55. 2 by synthetic peptides derived from the primary sequence J. Biol. Chem. 271 1996 23992 23998
56. W.B. Church, A.S. Inglis, A. Tseng, R. Duell, P.W. Lei, K.J. Bryant, and K.F. Scott A novel approach to the design of inhibitors of human secreted phospholipase A2 based on native peptide inhibition J. Biol. Chem. 276 2001 33156 33164
57. A.A. Takeda, J.I. dos Santos, S. Marcussi, L.B. Silveira, A.M. Soares, and M.R. Fontes Crystallization and preliminary X-ray diffraction analysis of an acidic phospholipase A(2) complexed with p-bromophenacyl bromide and alpha-tocopherol inhibitors at 1.9- and 1.45-A resolution Biochim. Biophys. Acta 1699 2004 281 284
58. 2 J. Med. Chem. 48 2005 893 896
59. 2 by indole analogues: a structure-guided study Bioorg. Med. Chem. 12 2004 1737 1749
60. J.C. McKew, F. Lovering, J.D. Clark, J. Bemis, Y. Xiang, M. Shen, W. Zhang, J.C. Alvarez, and D. Joseph-McCarthy Structure-activity relationships of indole cytosolic phospholipase A(2)alpha inhibitors: substrate mimetics Bioorg. Med. Chem. Lett. 13 2003 4501 4504
61. 2. 1. Indole-3-acetamides J. Med. Chem. 39 1996 5119 5136
62. 2. 2. Indole-3-acetamides with additional functionality J. Med. Chem. 39 1996 5137 5158
63. 2. 3. Indole-3-glyoxamides J. Med. Chem. 39 1996 5159 5175
64. V. Luzzati Traitement statistique des erreurs dans la determination des structures cristallines Acta Crystallogr. 5 1952 802 810
65. R.J. Read Improved Fourier coefficients for maps using phases from partial structures with errors Acta Crystallogr., A 42 1986 140 149
66. R.M. Esnouf An extensively modified version of Molscript that includes greatly enhanced coloring capabilities J. Mol. Graph. 15 1997 132 134
67. E.A. Merritt, and M.E.P. Murphy Raster 3D Version 2.0: a program for photorealistic molecular graphics Acta Crystallogr. D50 1994 869 873
68. A.C. Wallace, R.A. Laskowski, and J.M. Thornton LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions Protein Eng. 8 1995 127 134